Metraipolis › archive › dc_737befa32f85
Early Life Exposure to Perfluoroalkyl Substances (PFAS) and ADHD: A Meta-Analysis of Nine European Population-Based Studies — Europe PMC PMID:32378965
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32378965
- DOI
- 10.1289/ehp5444
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-08T19:23:16.766Z
- SHA-256 of the archived text
aaeddff106ade958042166e129adc4302f6bfa19738ad65dc1cd9803e9eaa7b9- Stable URL of this page
https://metraipolis.com/documento/dc_737befa32f85
How to cite
Early Life Exposure to Perfluoroalkyl Substances (PFAS) and ADHD: A Meta-Analysis of Nine European Population-Based Studies — Europe PMC PMID:32378965 — Europe PMC (en), https://europepmc.org/article/MED/32378965 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_737befa32f85 (Metraipolis archive dc_737befa32f85, sha256 aaeddff106ade958042166e129adc4302f6bfa19738ad65dc1cd9803e9eaa7b9)
BibTeX
@misc{dc737befa32f85,
title = {Early Life Exposure to Perfluoroalkyl Substances (PFAS) and ADHD: A Meta-Analysis of Nine European Population-Based Studies — Europe PMC PMID:32378965},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32378965},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_737befa32f85; sha256 aaeddff106ade958042166e129adc4302f6bfa19738ad65dc1cd9803e9eaa7b9},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32378965. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Introduction: To date, the evidence for an association between perfluoroalkyl substances (PFAS) exposure and attention deficit and hyperactivity disorder (ADHD) is inconclusive. Objective: We investigated the association between early life exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), and ADHD in a collaborative study including nine European population-based studies, encompassing 4,826 mother-child pairs. Methods: Concentrations of PFOS and PFOA were measured in maternal serum/plasma during pregnancy, or in breast milk, with different timing of sample collection in each cohort. We used a validated pharmacokinetic model of pregnancy and lactation to estimate concentrations of PFOS and PFOA in children at birth and at 3, 6, 12, and 24 months of age. We classified ADHD using recommended cutoff points for each instrument used to derive symptoms scores. We used multiple imputation for missing covariates, logistic regression to model the association between PFAS exposure and ADHD in each study, and combined all adjusted study-specific effect estimates using random-effects meta-analysis. Results: A total of 399 children were classified as having ADHD, with a prevalence ranging from 2.3% to 7.3% in the studies. Early life exposure to PFOS or PFOA was not associated with ADHD during childhood [odds ratios (ORs) ranging from 0.96 (95% CI: 0.87, 1.06) to 1.02 (95% CI: 0.93, 1.11)]. Results from stratified models suggest potential differential effects of PFAS related to child sex and maternal education. Conclusion: We did not identify an increased prevalence of ADHD in association with early life exposure to PFOS and PFOA. However, stratified analyses suggest that there may be an increased prevalence of ADHD in association with PFAS exposure in girls, in children from nulliparous women, and in children from low-educated mothers, all of which warrant further exploration. https://doi.org/10.1289/EHP5444. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2020 (prima pubblicazione 2020-05-06). Identificativi: PMID 32378965 · PMCID PMC7263458 · DOI 10.1289/ehp5444. Pagina: https://europepmc.org/article/MED/32378965 — https://doi.org/10.1289/ehp5444. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-08T19:19:29.242Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.